🔗 Share this article

Chancellor Reeves has revealed she is planning "focused measures to deal with cost of living issues" in the forthcoming Budget.

During an interview with media outlets, she stated that curbing price rises is a joint responsibility of both the administration and the central bank.

The UK's inflation rate is forecast to be the most elevated among the Group of Seven developed nations this year and the following year.

Potential Energy Cost Measures

Reports indicate the government could take action to bring down energy bills, for example by slashing the present 5% rate of value-added tax charged on energy.

Another approach is to cut some of the policy costs currently added to household expenses.

Fiscal Limitations and Expert Predictions

The government will receive the next report from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much room there is for these actions.

The consensus from most analysts is that the Chancellor will have to introduce tax rises or budget cuts in order to meet her self-imposed borrowing rules.

Previously on the same day, analysis showed there was a £22 billion deficit for the chancellor to fill, which is at the lower end of expectations.

"It is a collective responsibility between the Bank of England and the administration to further reduce some of the drivers of price increases," the Chancellor stated to reporters in the US capital, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and International Issues

While a great deal of the focus has been on probable tax rises, the Treasury chief said the latest data from the fiscal watchdog had not changed her commitment to campaign commitments not to raise rates on income tax, sales tax or social security contributions.

She blamed an "unpredictable world" with rising international and trade concerns for the fiscal tax moves, probably to be targeted on those "wealthiest."

International Trade Tensions

Addressing apprehensions about the UK's trade ties with China she said: "Our national security always come first."

Recent declaration by Chinese authorities to increase export controls on rare earths and other materials that are key for high-technology production led US President Donald Trump to propose an additional 100% tariff on goods from the Asian country, increasing the possibility of an full-scale commercial conflict between the two economic giants.

The American finance chief described the Chinese action "economic coercion" and "a international production control attempt."

Inquired about accepting the American proposal to join its battle with China, the Chancellor said she was "very concerned" by China's actions and encouraged the Chinese government "to avoid restrictions and restrict access."

She said the move was "damaging for the international commerce and creates further headwinds."

"In my view there are areas where we need to address China, but there are also significant opportunities to sell into China's economy, including banking sector and other sectors of the economic system. We've got to get that balance appropriate."

The chancellor also confirmed she was collaborating with other major economies "regarding our own critical minerals strategy, so that we are more independent."

NHS Medicine Costs and Investment

Reeves also admitted that the cost the NHS pays for pharmaceuticals could increase as a result of current discussions with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or abandoning operations in the United Kingdom, with several blaming the low prices they are getting.

Recently, the government science advisor said the price the NHS pays for medicines would need to go up to stop companies and drug research funding departing from the United Kingdom.

The Chancellor told media: "We have seen as a result of the payment system, that drug testing, recent pharmaceuticals have not been available in the United Kingdom in the extent that they are in other European countries."

"We want to make sure that people getting treatment from the NHS are able to receive the top life-saving treatments in the world. And so we are reviewing these issues, and... looking to obtain additional funding into the UK."